<p>Drug-Eluting Beads versus Lipiodol Transarterial Chemoembolization for the Treatment of Hypovascular Hepatocellular Carcinoma: A Single-Center Retrospective Study</p>-Reference-Cited by-同舟云学术

Drug-Eluting Beads versus Lipiodol Transarterial Chemoembolization for the Treatment of Hypovascular Hepatocellular Carcinoma: A Single-Center Retrospective Study

Published:2020-07 Issue: Volume:Volume 12 Page:5461-5468
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Shi Qin,Chen Dandan,Zhou Chen,Liu Jiacheng^ORCID,Huang Songjiang,Yang Chongtu,Xiong Bin^ORCID

Publisher

Informa UK Limited

Subject

Oncology

Reference31 articles.

1. Hepatocellular Carcinoma

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Imaging diagnosis and staging of hepatocellular carcinoma

4. Hypovascular hepatic nodules as a predictive factor for transcatheter arterial chemoembolization refractoriness in hepatocellular carcinoma

5. Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Inflammation-Based Staging System for Hepatocellular Carcinoma After Drug-Eluting Beads Transarterial Chemoembolization: A Multicenter Study;Academic Radiology;2024-08

2. Development of a predictive nomogram for postembolization syndrome after transcatheter arterial chemoembolization of hepatocellular carcinoma;Scientific Reports;2024-02-08

3. Tumor Response and Nomogram-Based Prognostic Stratification for Hepatocellular Carcinoma After Drug-Eluting Beads Transarterial Chemoembolization;Journal of Hepatocellular Carcinoma;2022-06

4. Prophylactic Use of Antibiotics for Postsurgical Infection in c-TACE and DEB-TACE High-Risk Patients: A Case-Control Study;Journal of Healthcare Engineering;2022-04-11

5. Combination therapy of sorafenib and drug-eluting bead transarterial chemoembolization for advanced hepatocellular carcinoma with and without hepatic arteriovenous shunt;Journal of the Chinese Medical Association;2022-02-08